1 / 6

Beaver Dam Eye Study: Overall Participant Flow

Beaver Dam Eye Study: Overall Participant Flow. Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758. Beaver Dam Eye Study: Flow of Participants From the Third Examination Who Were Eligible for Nuclear Cataract Analyses. Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758.

zenia-goodwin
Télécharger la présentation

Beaver Dam Eye Study: Overall Participant Flow

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Beaver Dam Eye Study: Overall Participant Flow Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

  2. Beaver Dam Eye Study: Flow of Participants From the Third Examination Who Were Eligible for Nuclear Cataract Analyses Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

  3. Distribution and Age-Adjusted ORs for Each Cataract Type Based on Statin Use Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

  4. Characteristics at the Third Examination (1998-2000) of Participants Who Developed Nuclear Cataract Compared With Those Who Did Not* Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

  5. Five-Year Incidence of Nuclear Cataract Identified at Fourth Examination, Classified by Use of Statins at Third Examination, 1998-2000 Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

  6. Incident Nuclear Cataract by Duration of Statin Use* Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

More Related